Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07082725
PHASE3

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

Sponsor: Azafaros A.G.

View on ClinicalTrials.gov

Summary

An 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in late-infantile and juvenile forms of Niemann-Pick type C disease

Official title: 18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

Key Details

Gender

All

Age Range

4 Years - Any

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2025-06-30

Completion Date

2027-11-04

Last Updated

2026-04-01

Healthy Volunteers

No

Interventions

DRUG

Nizubaglustat

AZ-3102

DRUG

Placebo

Matching placebo

Locations (33)

UCSF Children's Hospital and Research Center at Oakland

Oakland, California, United States

University of Minnesota Medical School

Minneapolis, Minnesota, United States

Children's Medical Center Dallas

Dallas, Texas, United States

Lysosomal Rare Disorders Research and Treatment Center

Fairfax, Virginia, United States

Hospital Universitario Austral

Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina

Hospital de Niños de La Santisima Trinidad

Córdoba, Córdoba Province, Argentina

Women's and Children's Hospital

North Adelaide, South Australia, Australia

Royal Melbourne Hospital

Parkville, Victoria, Australia

Royal Children's Hospital Melbourne - PIN

Parkville, Victoria, Australia

Instituto Fernandes Figueira

Rio de Janeiro, Rio de Janeiro, Brazil

Hospital de Clinicas de Porto Alegre (HCPA) - PPDS

Porto Alegre, Rio Grande do Sul, Brazil

Hospital Pequeno Principe

Curitiba, Brazil

M.A.G.I.C. Clinic Ltd. Metabolics and Genetics in Calgary

Calgary, Alberta, Canada

University of Alberta Medical Genetics Clinic

Edmonton, Alberta, Canada

Centre Hospitalier de l'Universite de Montreal-1000 rue Saint-Denis

Montreal, Quebec, Canada

SphinCS GmbH

Höchheim, Germany

Amrita Institute of Medical Sciences and Research Centre

Ernākulam, Kerala, India

All India Institute of Medical Sciences (AIIMS) - New Delhi

New Delhi, National Capital Territory of Delhi, India

JK Lone Hospital

Jaipur, Rajasthan, India

Christian Medical College and Hospital

Vellore, Tamil Nadu, India

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Italy

Hospital Universitario Dr. Jose Eleuterio González

Monterrey, Nuevo León, Mexico

Centenario Hospital Miguel Hidalgo

Aguascalientes, Mexico

ULS de Santo António, EPE - Centro Materno Infantil Norte

Porto, Porto District, Portugal

Hospital Universitario Vall d'Hebron - PPDS

Barcelona, Barcelona, Spain

Hospital Infantil Universitario Niño Jesus - PIN

Madrid, Madrid, Spain

Inselspital - Universitätsspital Bern

Bern, Canton of Bern, Switzerland

Balcali Hastanesi Saglik Uygulama ve Arastirma Merkezi

Adana, Adana, Turkey (Türkiye)

Gazi Universitesi Saglik Arastirma ve Uygulama Merkezi

Çankaya, Ankara, Turkey (Türkiye)

Ege Universitesi Tip Fakultesi

Bornova, İzmir, Turkey (Türkiye)

Great Ormond Street Hospital

London, London, United Kingdom

University College London Hospitals (UCLH)

London, Middlesex, United Kingdom

Royal Manchester Children's Hospital

Manchester, United Kingdom